HomeNewsPoliticsEC extends ban on physical rallies and roadshows in five states till January 22

EC extends ban on physical rallies and roadshows in five states till January 22

However, political parties can hold indoor meetings of maximum of 300 people or 50 percent of the capacity of the hall or the prescribed limit set by State Disaster Management Authority (SDMA), the Election Commission said.

January 15, 2022 / 18:08 IST
Story continues below Advertisement
Source: Reuters
Source: Reuters

The Election Commission of India on January 15 extended the ban on public rallies in five poll-bound states by a week until January 22 in view of the rising COVID-19 cases.

The poll panel, however, granted relaxation for the political parties by allowing indoor meetings of maximum of 300 persons or 50 per cent of the capacity of the hall or the prescribed limit set by State Disaster Management Authority (SDMA).

Story continues below Advertisement

READ : MC Election Update January 15: Congress releases first list of candidates for Punjab; Sidhu to contest polls from Amritsar East

The Commission, while announcing the schedule of assembly election in five states on January 8, had announced ban on public rallies and meetings till January 15.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

"No road show, pad-yatra, cycle/bike/vehicle rally and procession shall be allowed till January 22. No physical rallies of political parties or candidates (including probable) or any other shall be allowed till January 22," the Commission said in a statement adding that it will subsequently review the situation and issue further instructions accordingly.